Microsomal Cytochromes P450 and their Interactions with their Redox Partners

微粒体细胞色素 P450 及其与氧化还原伙伴的相互作用

基本信息

  • 批准号:
    8641389
  • 负责人:
  • 金额:
    $ 35.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The cytochrome P450 (cyt P450) superfamily consists of more than 11,000 members. They are ubiquitous, being found in all kingdoms of living organisms and plants and are referred to as Mother Nature's blowtorch, due to their ability to oxidize a vast number of stable chemical entities. Humans possess 56 different cyts P450, many of which are essential for early development and life itself. Other human cyts P450 determine the toxicity, duration of action, and elimination of the vast majority of therapeutic agents, carcinogens, and environmental agents to which humans are exposed. Xenobiotic metabolizing cyts P450 are also responsible for the majority of drug-drug interactions and adverse drug reactions. A third group of cyts P450 are responsible for the biosynthesis or metabolism of essential endogenous compounds. This includes virtually all steroids (cholesterol, bile acids, estrogens, testosterone, cortisol, and vitamin D) and many lipids and eicosanoids. Cyts P450 exists in virtually every organ and tissue of humans. The cyts P450 are not self-sufficient but rather require interactions with other proteins in order to function. Cyt P450 reductase and cytochrome b5 (cyt b5), which provide electrons to cyt P450, are two proteins that support the activity of cyt P450. The long-term goal of this project is to understand the structural and mechanistic basis for the regulation of the activity of the membrane-bound microsomal cyts P450 by its redox partners, cyt P450 reductase and cyt b5. The short-term goals of this proposal, using both human and model cyts P450, are to understand the biochemical basis of how the redox partners of cyt P450 regulate its activity, substrate specificity, and catalytic mechanism. Experimental techniques, including site-directed mutagenesis, rapid quenching of cyt P450 activity by chemical means, and freezing, HPLC-mass spectrometry, and quantum mechanical/molecular mechanical calculations will be employed to elucidate how the activity of microsomal cyts P450 is regulated by its redox partners. Understanding how nature designs cyt P450 active sites is a fundamental question with implications for predicting and eventually modifying the routes of metabolism of a large number of environmental contaminants such as phthalates, bisphenol A, polychlorinated biphenyls (PCBs) and many currently used drugs, including chemotherapeutic agents, psychoactive compounds, and cardiovascular therapies. Knowledge of the molecular mechanism by which the activity of human cyts P450 can be regulated will also prove to be a tremendous asset in developing drugs and procedures to alter the large number of critical physiologic processes in which the human cyts P450 participate, as well as in designing less toxic and more specific therapeutic agents and prodrugs, especially chemotherapeutic agents and environmental contaminants.
描述(由申请人提供):细胞色素P450(CYT P450)超家族由11,000多名成员组成。它们无处不在,在所有生物体和植物的王国中都被发现,由于它们能够氧化大量稳定的化学实体,因此被称为大自然母亲的大自然。人类拥有56种不同的CYT P450,其中许多对于早期发展和生命本身至关重要。其他人类细胞P450决定了绝大多数治疗剂,致癌物和人类暴露的环境药物的毒性,作用持续时间和消除。异种生物代谢Cyts P450还负责大多数药物相互作用和不良药物反应。第三组CYTS P450负责基本内源性化合物的生物合成或代谢。这实际上包括所有类固醇(胆固醇,胆汁酸,雌激素,睾丸激素,皮质醇和维生素D)以及许多脂质和eicosanoids。 Cyts P450几乎存在于人类的每个器官和组织中。 Cyts P450不是自给自足的,而是需要与其他蛋白质相互作用才能发挥作用。 Cyt P450还原酶和细胞色素B5(Cyt B5)为Cyt P450提供电子,是两个支持Cyt P450活性的蛋白。该项目的长期目标是了解调节膜结合的微粒体Cyts P450的结构和机械基础,其氧化还原伙伴,Cyt P450还原酶和CytT B5。 该提案的短期目标使用人类和模型Cyts P450,是为了了解Cyt P450的氧化还原伴侣如何调节其活性,底物特异性和催化机制的生化基础。实验技术,包括定位的诱变,化学方法对Cyt P450活性的快速淬火,冰冻,HPLC-MAS谱图以及量子力学/分子机械计算将如何阐明如何通过其氧化还原型伙伴调节微粒体Cyts P450的活性。 Understanding how nature designs cyt P450 active sites is a fundamental question with implications for predicting and eventually modifying the routes of metabolism of a large number of environmental contaminants such as phthalates, bisphenol A, polychlorinated biphenyls (PCBs) and many currently used drugs, including chemotherapeutic agents, psychoactive compounds, and cardiovascular therapies.了解可以调节人类CYT p450活性的分子机制的知识也将被证明是开发药物和程序的巨大资产,以改变人类Cyts P450参与的大量关键生理过程,以及设计毒性较低的毒性和更具体的治疗剂,尤其是毒品和produggs和Orthereprugs和Ortherepicational和Ortherepicational和Ortectimant和Ortherepicational和Ortherepicational和Ortherepicational和Ortectimant和Ortectimant和Envormation and overational和Otherapectication。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A single-site mutation (F429H) converts the enzyme CYP 2B4 into a heme oxygenase: a QM/MM study.
单位点突变 (F429H) 将 CYP 2B4 酶转化为血红素加氧酶:一项 QM/MM 研究。
  • DOI:
    10.1021/ja211905e
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Usharani,Dandamudi;Zazza,Costantino;Lai,Wenzhen;Chourasia,Mukesh;Waskell,Lucy;Shaik,Sason
  • 通讯作者:
    Shaik,Sason
How Do Perfluorinated Alkanoic Acids Elicit Cytochrome P450 to Catalyze Methane Hydroxylation? An MD and QM/MM Study.
  • DOI:
    10.1039/c2ra22294a
  • 发表时间:
    2013-03-07
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Li C;Shaik S
  • 通讯作者:
    Shaik S
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LUCY A WASKELL其他文献

LUCY A WASKELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LUCY A WASKELL', 18)}}的其他基金

Microsomal Cytochromes P450 and their Interactions with their Redox Partners
微粒体细胞色素 P450 及其与氧化还原伙伴的相互作用
  • 批准号:
    8447079
  • 财政年份:
    2011
  • 资助金额:
    $ 35.61万
  • 项目类别:
Microsomal Cytochromes P450 and their Interactions with their Redox Partners
微粒体细胞色素 P450 及其与氧化还原伙伴的相互作用
  • 批准号:
    8244399
  • 财政年份:
    2011
  • 资助金额:
    $ 35.61万
  • 项目类别:
Microsomal Cytochromes P450 and their Interactions with their Redox Partners
微粒体细胞色素 P450 及其与氧化还原伙伴的相互作用
  • 批准号:
    8108965
  • 财政年份:
    2011
  • 资助金额:
    $ 35.61万
  • 项目类别:
WHY DO SUBSTRATES REQUIRE CYTOCHROME B5 FOR OXIDATION BY CYTOCHROME P450
为什么底物需要细胞色素 B5 才能被细胞色素 P450 氧化
  • 批准号:
    6119109
  • 财政年份:
    1999
  • 资助金额:
    $ 35.61万
  • 项目类别:
WHY DO SUBSTRATES REQUIRE CYTOCHROME B5 FOR OXIDATION BY CYTOCHROME P450
为什么底物需要细胞色素 B5 才能被细胞色素 P450 氧化
  • 批准号:
    6280130
  • 财政年份:
    1998
  • 资助金额:
    $ 35.61万
  • 项目类别:
PARTICIPATION OF CYTOCHROME B5 IN ANESTHETIC METABOLISM
细胞色素 B5 参与麻醉代谢
  • 批准号:
    2177948
  • 财政年份:
    1985
  • 资助金额:
    $ 35.61万
  • 项目类别:
PARTICIPATION OF CYTOCHROME B5 IN ANESTHETIC METABOLISM
细胞色素 B5 参与麻醉代谢
  • 批准号:
    2177950
  • 财政年份:
    1985
  • 资助金额:
    $ 35.61万
  • 项目类别:
PARTICIPATION OF CYTOCHROME B5 IN ANESTHETIC METABOLISM
细胞色素 B5 参与麻醉代谢
  • 批准号:
    6046025
  • 财政年份:
    1985
  • 资助金额:
    $ 35.61万
  • 项目类别:
PARTICIPATION OF CYTOCHROME B5 IN ANESTHETIC METABOLISM
细胞色素 B5 参与麻醉代谢
  • 批准号:
    3288451
  • 财政年份:
    1985
  • 资助金额:
    $ 35.61万
  • 项目类别:
Participation of Cytochrome b5 in Anesthetic Metabolism
细胞色素 b5 参与麻醉代谢
  • 批准号:
    7214130
  • 财政年份:
    1985
  • 资助金额:
    $ 35.61万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Rationalizing glycoengineering strategies for immunotherapeutic antibodies
免疫治疗抗体糖工程策略的合理化
  • 批准号:
    10377400
  • 财政年份:
    2020
  • 资助金额:
    $ 35.61万
  • 项目类别:
Mechanistic basis of bacteriophages for the decolonization of vancomycin resistant enterococci in the intestine
噬菌体在肠道内去定植耐万古霉素肠球菌的机制基础
  • 批准号:
    10810149
  • 财政年份:
    2018
  • 资助金额:
    $ 35.61万
  • 项目类别:
Mechanisms of Gamma-Secretase
γ-分泌酶的机制
  • 批准号:
    10004095
  • 财政年份:
    2017
  • 资助金额:
    $ 35.61万
  • 项目类别:
Mechanisms of Gamma-Secretase
γ-分泌酶的机制
  • 批准号:
    9566224
  • 财政年份:
    2017
  • 资助金额:
    $ 35.61万
  • 项目类别:
Regulation of SAMHD1 antiviral activity
SAMHD1 抗病毒活性的调节
  • 批准号:
    8877038
  • 财政年份:
    2014
  • 资助金额:
    $ 35.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了